Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
101.60    -1.60 (-1.55%)
Bid:
101.60
Ask:
102.60
Spread: 1.00 (0.984%)
Market Cap: £166.57m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

8 Nov 2012 07:00

RNS Number : 6049Q
Yule Catto & Co PLC
08 November 2012
 



YULE CATTO & CO PLC

 

INTERIM MANAGEMENT STATEMENT

 

Continued resilient performance; Intention to change Group name

 

Yule Catto & Co plc ("Yule Catto" or "the Group") today issues its interim management statement for the period 1 July to 8 November 2012. The Group also announces its intention to change its name to Synthomer plc.

 

Trading

 

The Group has continued to perform in line with the Board's expectations since the last update provided at the interim results in August, despite the challenging macro-economic conditions, particularly in Europe.

 

In Europe and North America, profit to date remains well ahead of prior year. This has been achieved notwithstanding year to date volumes down 10%, and an adverse translation impact of £4.5 million in the first nine months of the year due to the weaker euro. This performance reflects the continued benefits of good margin management and synergy delivery which the Group has achieved during the period. Demand remains subdued with construction related areas continuing to be particularly affected. 

 

In Asia and ROW, the non-nitrile businesses continued the positive momentum achieved in the first half. Our Nitrile business is trading in line with the guidance provided at the interim results.

 

We continue to make strong progress with synergy delivery from the PolymerLatex acquisition, and remain firmly on track to realise £19 million of synergies in the current year, a year on year improvement of £16 million. The Group continues to expect to deliver the total £25 million of targeted annual synergies by March 2013. 

 

The Group's financial position remains robust with net debt at the end of September at £160 million, down from £174 million at the half year.

 

Outlook

 

The Board's expectations remain unchanged from those stated at the half year. Full year underlying profit before tax is expected to be ahead of 2011 pro-forma of £96 million.

 

Intention to change Group name to Synthomer plc

 

Over the last 5 years the Group has been transformed from a small, diversified chemical business, of which Yule Catto was the holding company, to a much larger, focussed speciality polymer business. The Group trades under the name Synthomer across the majority of its business, and the Board has therefore decided that now is an appropriate time to reflect this in the Group's name.

 

The Group will convene an Extraordinary General Meeting in on December 4 where shareholders will be asked to approve this change. If shareholders agree to this proposal, the Group's name will be changed to Synthomer plc before the year end. A circular to this effect will be distributed to shareholders today.

 

Commenting Adrian Whitfield, Group Chief Executive, said:

 

"We are pleased to have delivered a resilient performance in difficult market conditions. The Group's strong portfolio of products and leading market positions provide an excellent platform for growth and we remain confident of continuing to deliver value for our shareholders."

 

Enquiries:

 

Adrian Whitfield, Group Chief Executive

Charles Armitstead / Rosie Oddy

David Blackwood, Group Finance Director

Pendomer Communications

Tel: 01279 442791

Tel: 020 3603 5220

 

 

The company will host a conference call for analysts at 8.00am today. Please contact Pendomer Communications on 020 3603 5220 for dial in details.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLLFFALLLDIIF
Date   Source Headline
17th May 20077:01 amRNSAGM Statement
15th May 20074:29 pmRNSAnnual Report and Accounts
20th Apr 20079:40 amRNSAnnual Information Update
19th Apr 200712:47 pmRNSHolding(s) in Company
10th Apr 20075:26 pmRNSDirectorate Change
29th Mar 20074:37 pmRNSHolding(s) in Company
22nd Mar 200712:30 pmRNSDirectorate Change
12th Mar 20071:05 pmRNSDirector/PDMR Shareholding
12th Mar 20071:00 pmRNSDirector/PDMR Shareholding
7th Mar 20077:01 amRNSFinal Results
6th Mar 20074:04 pmRNSHolding(s) in Company
20th Feb 20074:29 pmRNSNotice of Results
1st Feb 20074:23 pmRNSBlocklisting Interim Review
18th Dec 20062:08 pmRNSVoting Rights and Capital
15th Dec 20067:58 amRNSTrading Statement
4th Dec 200612:49 pmRNSBlocklisting Interim Review
12th Oct 200610:46 amRNSHolding(s) in Company
2nd Oct 20063:20 pmRNSDirector/PDMR Shareholding
8th Sep 20069:01 amRNSDirector/PDMR Shareholding
7th Sep 20067:01 amRNSInterim Results
21st Aug 20063:22 pmRNSNotice of Results
21st Aug 20062:41 pmRNSDirectorate Change
1st Aug 20062:51 pmRNSBlocklisting Interim Review
14th Jul 20063:51 pmRNSNew Chief Executive
7th Jun 200611:14 amRNSDirector/PDMR Shareholding
5th Jun 20067:00 amRNSDisposal of Reabrook Limited
1st Jun 20064:48 pmRNSBlocklisting Interim Review
25th May 20063:11 pmRNSDirector/PDMR Shareholding
25th May 20063:09 pmRNSDirector/PDMR Shareholding
18th May 20064:59 pmRNSResult of AGM
18th May 200612:00 pmRNSAGM Statement
3rd May 200612:28 pmRNSAnnual Information Update
18th Apr 20063:49 pmRNSAnnual Report and Accounts
13th Apr 200611:30 amRNSDirector/PDMR Shareholding
13th Apr 200611:28 amRNSDirector/PDMR Shareholding
21st Mar 200612:05 pmRNSDirector/PDMR Shareholding
16th Mar 20067:01 amRNSFinal Results
20th Feb 20063:44 pmRNSHolding(s) in Company
20th Feb 20062:00 pmRNSAppointment
9th Feb 200612:10 pmRNSNotice of Results
31st Jan 200610:00 amRNSAdditional Listing
30th Dec 200512:00 pmRNSWithdrawal from SO2 business
23rd Dec 200510:14 amRNSDirector/PDMR Shareholding
14th Dec 20057:00 amRNSPre-close Trading Statement
8th Dec 20051:29 pmRNSBlocklisting Interim Review
7th Dec 20058:42 amRNSSale of Autoclenz Limited
7th Dec 20057:01 amRNSAdmission to trading on AIM
6th Dec 20054:23 pmRNSDirector Declaration
6th Dec 20054:18 pmRNSDirectorate Change
2nd Dec 200510:07 amRNSSale of Autoclenz Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.